Hong Kong Stock Market Surges | Fosun Pharma (02696.HK) rises nearly 6% in the afternoon, with the completion of the first patient dosed in the Phase III clinical trial HLX22, which is expected to change the standard treatment for first-line gastric cancer.
According to the Securities Times app, Fuhong Hanlin (02696.HK) surged nearly 6% in the afternoon, with a 5.78% increase as of press time, reaching 63.1 Hong Kong dollars with a trading volume of 1.07 billion Hong Kong dollars.
Latest
